Design of a cyclotide antagonist of neuropilin-1 and -2 that potently inhibits endothelial cell migration

ACS Chemical Biology

Volumn 8, Issue 6, 2013, Pages 1147-1154

  Getz, Jennifer A ^a   Cheneval, Olivier ^b   Craik, David J ^b   Daugherty, Patrick S ^a  

^a University of California   (United States)

^b UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOTIDE; CYCLOTIDE N2.1; CYCLOTIDE N2.1C; CYCLOTIDE N2.2; CYCLOTIDE N2.6; NEUROPILIN 1; NEUROPILIN 2; PROTEINASE; UNCLASSIFIED DRUG; VASCULOTROPIN RECEPTOR;

AMINO ACID SEQUENCE; ARTICLE; BINDING SITE; BREAST CANCER; CELL MIGRATION; CYCLIZATION; DRUG PROTEIN BINDING; ENDOTHELIUM CELL; FLOW CYTOMETRY; IN VITRO STUDY; PRIORITY JOURNAL; PROSTATE CANCER;

AMINO ACID SEQUENCE; ANIMALS; CELL MOVEMENT; ENDOTHELIAL CELLS; HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS; HUMANS; MICE; MODELS, MOLECULAR; MOLECULAR SEQUENCE DATA; NEUROPILIN-1; NEUROPILIN-2; PEPTIDES;

BACTERIA (MICROORGANISMS);

EID: 84879005229     PISSN: 15548929     EISSN: 15548937     Source Type: Journal    
DOI: 10.1021/cb4000585     Document Type: Article

References (39)

1. Rizzolio, S. and Tamagnone, L. (2011) Multifaceted role of neuropilins in cancer Curr. Med. Chem. 18, 3563-3575
2. Soker, S., Fidder, H., Neufeld, G., and Klagsbrun, M. (1996) Characterization of novel vascular endothelial growth factor (VEGF) receptors on tumor cells that bind VEGF via its exon 7-encoded domain J. Biol. Chem. 271, 5761-5767
3. Soker, S., Takashima, S., Miao, H. Q., Neufeld, G., and Klagsbrun, M. (1998) Neuropilin-1 is expressed by endothelial and tumor cells as an isoform-specific receptor for vascular endothelial growth factor Cell 92, 735-745
4. Bachelder, R. E., Crago, A., Chung, J., Wendt, M. A., Shaw, L. M., Robinson, G., and Mercurio, A. M. (2001) Vascular endothelial growth factor is an autocrine survival factor for neuropilin-expressing breast carcinoma cells Cancer Res. 61, 5736-5740
5. Hu, B., Guo, P., Bar-Joseph, I., Imanishi, Y., Jarzynka, M. J., Bogler, O., Mikkelsen, T., Hirose, T., Nishikawa, R., and Cheng, S. Y. (2007) Neuropilin-1 promotes human glioma progression through potentiating the activity of the HGF/SF autocrine pathway Oncogene 26, 5577-5586
6. Ochiumi, T., Kitadai, Y., Tanaka, S., Akagi, M., Yoshihara, M., and Chayama, K. (2006) Neuropilin-1 is involved in regulation of apoptosis and migration of human colon cancer Int. J. Oncol. 29, 105-116
7. Wey, J. S., Gray, M. J., Fan, F., Belcheva, A., McCarty, M. F., Stoeltzing, O., Somcio, R., Liu, W., Evans, D. B., Klagsbrun, M., Gallick, G. E., and Ellis, L. M. (2005) Overexpression of neuropilin-1 promotes constitutive MAPK signalling and chemoresistance in pancreatic cancer cells Br. J. Cancer 93, 233-241
8. Matsushita, A., Götze, T., and Korc, M. (2007) Hepatocyte growth factor-mediated cell invasion in pancreatic cancer cells is dependent on neuropilin-1 Cancer Res. 67, 10309-10316
9. Rizzolio, S., Rabinoviz, N., Rainero, E., Lanzetti, L., Serini, G., Norman, J. C., Neufeld, G., and Tamagnone, L. (2012) Neuropilin-1 dependent regulation of EGF-Receptor signaling Cancer Res. 17, 5801-5811
10. Pan, Q., Chanthery, Y., Liang, W.-C., Stawicki, S., Mak, J., Rathore, N., Tong, R. K., Kowalski, J., Yee, S. F., Pacheco, G., Ross, S., Cheng, Z., Le Couter, J., Plowman, G., Peale, F., Koch, A. W., Wu, Y., Bagri, A., Tessier-Lavigne, M., and Watts, R. J. (2007) Blocking neuropilin-1 function has an additive effect with anti-VEGF to inhibit tumor growth Cancer Cell 11, 53-67
11. Xin, Y., Bai, S., Damico-Beyer, L., Jin, D., Liang, W.-C., Wu, Y., Theil, F.-P., Joshi, A., Lu, Y., Lowe, J., Maia, M., Brachmann, R., and Xiang, H. (2012) Anti-neuropilin-1 (MNRP1685A): Unexpected pharmacokinetic differences across species, from preclinical models to humans Pharm. Res. 29, 2512-2521
12. Bumbaca, D., Xiang, H., Boswell, C. A., Port, R. E., Stainton, S. L., Mundo, E. E., Ulufatu, S., Bagri, A., Theil, F.-P., Fielder, P. J., Khawli, L. A., and Shen, B.-Q. (2012) Maximizing tumour exposure to anti-neuropilin-1 antibody requires saturation of non-tumour tissue antigenic sinks in mice Br. J. Pharmacol. 166, 368-377
13. Sugahara, K. N., Teesalu, T., Karmali, P. P., Kotamraju, V. R., Agemy, L., Greenwald, D. R., and Ruoslahti, E. (2010) Coadministration of a tumor-penetrating peptide enhances the efficacy of cancer drugs Science 328, 1031-1035
14. Sugahara, K. N., Teesalu, T., Karmali, P. P., Kotamraju, V. R., Agemy, L., Girard, O. M., Hanahan, D., Mattrey, R. F., and Ruoslahti, E. (2009) Tissue-penetrating delivery of compounds and nanoparticles into tumors Cancer Cell 16, 510-520
15. Caunt, M., Mak, J., Liang, W.-C., Stawicki, S., Pan, Q., Tong, R. K., Kowalski, J., Ho, C., Reslan, H. B., Ross, J., Berry, L., Kasman, I., Zlot, C., Cheng, Z., Le Couter, J., Filvaroff, E. H., Plowman, G., Peale, F., French, D., Carano, R., Koch, A. W., Wu, Y., Watts, R. J., Tessier-Lavigne, M., and Bagri, A. (2008) Blocking neuropilin-2 function inhibits tumor cell metastasis Cancer Cell 13, 331-342
16. Čemažar, M. and Craik, D. (2006) Factors influencing the stability of cyclotides: proteins with a circular backbone and cystine knot motif Int. J. Pept. Res. Ther. 12, 253-260
17. Getz, J. A., Rice, J. J., and Daugherty, P. S. (2011) Protease-resistant peptide ligands from a knottin scaffold library ACS Chem. Biol. 6, 837-844
18. Wong, C. T. T., Rowlands, D. K., Wong, C.-H., Lo, T. W. C., Nguyen, G. K. T., Li, H.-Y., and Tam, J. P. (2012) Orally active peptidic bradykinin B1 receptor antagonists engineered from a cyclotide scaffold for inflammatory pain treatment Angew. Chem., Int. Ed. 124, 5718-5722
19. Eliasen, R., Daly, N. L., Wulff, B. S., Andresen, T. L., Conde-Frieboes, K. W., and Craik, D. J. (2012) Design, synthesis, structural and functional characterization of novel melanocortin agonists based on the cyclotide kalata B1 J. Biol. Chem. 287, 40493-40501
20. Haspel, N., Zanuy, D., Nussinov, R., Teesalu, T., Ruoslahti, E., and Aleman, C. (2011) Binding of a C-end rule peptide to the neuropilin-1 receptor: a molecular modeling approach Biochemistry 50, 1755-1762
21. He, Z. and Tessier-Lavigne, M. (1997) Neuropilin is a receptor for the axonal chemorepellent semaphorin III Cell 90, 739-751
22. Teesalu, T., Sugahara, K. N., Kotamraju, V. R., and Ruoslahti, E. (2009) C-end rule peptides mediate neuropilin-1-dependent cell, vascular, and tissue penetration Proc. Natl. Acad. Sci. U.S.A. 106, 16157-16162
23. Claffey, K. P., Brown, L. F., Del Aguila, L. F., Tognazzi, K., Yeo, K.-T., Manseau, E. J., and Dvorak, H. F. (1996) Expression of vascular permeability factor/vascular endothelial growth factor by melanoma cells increases tumor growth, angiogenesis, and experimental metastasis Cancer Res. 56, 172-181
24. Roth, L., Agemy, L., Kotamraju, V. R., Braun, G., Teesalu, T., Sugahara, K. N., Hamzah, J., and Ruoslahti, E. (2011) Transtumoral targeting enabled by a novel neuropilin-binding peptide Oncogene 31, 3754-3763
25. Daly, N. L., Love, S., Alewood, P. F., and Craik, D. J. (1999) Chemical synthesis and folding pathways of large cyclic polypeptides: studies of the cystine knot polypeptide kalata B1 Biochemistry 38, 10606-10614
26. Liang, W.-C., Dennis, M. S., Stawicki, S., Chanthery, Y., Pan, Q., Chen, Y., Eigenbrot, C., Yin, J., Koch, A. W., Wu, X., Ferrara, N., Bagri, A., Tessier-Lavigne, M., Watts, R. J., and Wu, Y. (2007) Function blocking antibodies to neuropilin-1 generated from a designed human synthetic antibody phage library J. Mol. Biol. 366, 815-829
27. Gruber, C. W., Čemažar, M., Clark, R. J., Horibe, T., Renda, R. F., Anderson, M. A., and Craik, D. J. (2007) A novel plant protein-disulfide isomerase involved in the oxidative folding of cystine knot defense proteins J. Biol. Chem. 282, 20435-20446
28. Parker, M. W., Xu, P., Li, X., and Vander Kooi, C. W. (2012) Structural basis for the selective vascular endothelial growth factor-A (VEGF-A) binding to neuropilin-1 J. Biol. Chem. 287, 11082-11089
29. Soman, N. R., Baldwin, S. L., Hu, G., Marsh, J. N., Lanza, G. M., Heuser, J. E., Arbeit, J. M., Wickline, S. A., and Schlesinger, P. H. (2009) Molecularly targeted nanocarriers deliver the cytolytic peptide melittin specifically to tumor cells in mice, reducing tumor growth J. Clin. Invest. 119, 2830-2842
30. Cascales, L., Henriques, S. T., Kerr, M. C., Huang, Y.-H., Sweet, M. J., Daly, N. L., and Craik, D. J. (2011) Identification and characterization of a new family of cell-penetrating peptides J. Biol. Chem. 286, 36932-36943
31. Owen, K. A., Qiu, D., Alves, J., Schumacher, A. M., Kilpatrick, L. M., Li, J., Harris, J. L., and Ellis, V. (2010) Pericellular activation of hepatocyte growth factor by the transmembrane serine proteases matriptase and hepsin, but not by the membrane-associated protease uPA Biochem. J. 426, 219-228
32. Kong, D., Li, Y., Wang, Z., Banerjee, S., and Sarkar, F. H. (2007) Inhibition of angiogenesis and invasion by 3,3′-diindolylmethane is mediated by the nuclear factor-κB downstream target genes MMP-9 and uPA that regulated bioavailability of vascular endothelial growth factor in prostate cancer Cancer Res. 67, 3310-3319
33. Bajou, K., Lewalle, J.-M., Martinez, C. R., Soria, C., Lu, H., Noël, A., and Foidart, J.-M. (2002) Human breast adenocarcinoma cell lines promote angiogenesis by providing cells with uPA-PAI-1 and by enhancing their expression Int. J. Cancer 100, 501-506
34. Taraboletti, G., D'Ascenzo, S., Borsotti, P., Giavazzi, R., Pavan, A., and Dolo, V. (2002) Shedding of the matrix metalloproteinases MMP-2, MMP-9, and MT1-MMP as membrane vesicle-associated components by endothelial cells Am. J. Pathol. 160, 673-680
35. Jia, H., Bagherzadeh, A., Hartzoulakis, B., Jarvis, A., Löhr, M., Shaikh, S., Aqil, R., Cheng, L., Tickner, M., Esposito, D., Harris, R., Driscoll, P. C., Selwood, D. L., and Zachary, I. C. (2006) Characterization of a bicyclic peptide neuropilin-1 (NP-1) antagonist (EG3287) reveals importance of vascular endothelial growth factor exon 8 for NP-1 binding and role of NP-1 in KDR signaling J. Biol. Chem. 281, 13493-13502
36. Kenrick, S., Rice, J., and Daugherty, P. (2007) Flow cytometric sorting of bacterial surface-displayed libraries Curr. Protoc. Cytom. 42, 4.6.1-4.6.27
37. Dane, K. Y., Gottstein, C., and Daugherty, P. S. (2009) Cell surface profiling with peptide libraries yields ligand arrays that classify breast tumor subtypes Mol. Cancer Ther. 8, 1312-1318
38. Getz, J. A., Schoep, T. S., and Daugherty, P. S. (2012) Peptide discovery using bacterial display and flow cytometry, in Methods in Enzymology: Protein Engineering for Therapeutics, Part A (Wittrup, K. D., Ed.) 1 st ed., pp 75-97, Academic Press, San Diego, CA.
39. Giebel, L. B., Cass, R., Milligan, D. L., Young, D., Arze, R., and Johnson, C. (1995) Screening of cyclic peptide phage libraries identifies ligands that bind streptavidin with high affinities Biochemistry 34, 15430-15435